|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000120093 |
Summary for HOXB3 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000120093 | Gene symbol | HOXB3 |
| Gene name | homeobox B3 | |
| HGNC | 5114 | |
| Entrez ID | 3213 | |
| Gene type | protein_coding | |
| Synonyms | HOXB3| | |
| UniProtAcc | P14651 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for HOXB3 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| HOXB3 | 1.81e+03 | 1.82e+00 | 5.02e-01 | 3.63e+00 | 2.84e-04 | 1.11e-03 | BLCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| HOXB3 | 1.18e+03 | 1.37e+00 | 3.32e-01 | 4.12e+00 | 3.79e-05 | 1.14e-04 | LUSC |
| HOXB3 | 1.35e+03 | 1.10e+00 | 3.82e-01 | 2.87e+00 | 4.13e-03 | 1.17e-02 | READ |
Top |
Sex-biased somatic mutation for HOXB3 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for HOXB3 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg15435170 | chr17:48603773 | CGI:chr17:48607882-48608087 | promoter,gene body | 4.12e-01 | 2.70e-01 | 2.09e+00 | 3.64e-02 | 4.42e-02 | 1.41e-01 |
| BRCA | cg00072689 | chr17:48603749 | CGI:chr17:48607882-48608087 | promoter,gene body | 3.75e-01 | 2.72e-01 | 1.97e+00 | 4.85e-02 | 4.94e-02 | 1.03e-01 |
| BRCA | cg01986016 | chr17:48603792 | CGI:chr17:48607882-48608087 | promoter,gene body | 3.53e-01 | 2.50e-01 | 2.20e+00 | 2.78e-02 | 3.97e-02 | 1.03e-01 |
| BRCA | cg16848873 | chr17:48604946 | CGI:chr17:48607882-48608087 | promoter | 4.39e-01 | 2.74e-01 | 2.25e+00 | 2.48e-02 | 3.79e-02 | 1.65e-01 |
| LIHC | cg04435975 | chr17:48605685 | CGI:chr17:48607882-48608087 | promoter | 3.40e-01 | 2.39e-01 | 2.28e+00 | 2.27e-02 | 3.02e-02 | 1.01e-01 |
| MESO | cg18684142 | chr17:48605032 | CGI:chr17:48607882-48608087 | promoter | 2.79e-01 | 4.45e-01 | -2.07e+00 | 3.89e-02 | 4.73e-02 | -1.65e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg10906729 | chr17:48605028 | CGI:chr17:48607882-48608087 | promoter | 1.40e-01 | 3.48e-02 | 6.41e+00 | 1.50e-10 | 3.37e-09 | 1.05e-01 |
| HNSC | cg17179862 | chr17:48604000 | CGI:chr17:48607882-48608087 | promoter,gene body | 3.51e-01 | 2.10e-01 | 2.70e+00 | 6.92e-03 | 9.37e-03 | 1.41e-01 |
| HNSC | cg03803541 | chr17:48604039 | CGI:chr17:48607882-48608087 | promoter,gene body | 3.39e-01 | 1.92e-01 | 3.23e+00 | 1.25e-03 | 2.20e-03 | 1.47e-01 |
| HNSC | cg10906729 | chr17:48605028 | CGI:chr17:48607882-48608087 | promoter | 5.33e-01 | 3.47e-01 | 2.35e+00 | 1.90e-02 | 2.20e-02 | 1.85e-01 |
| HNSC | cg18684142 | chr17:48605032 | CGI:chr17:48607882-48608087 | promoter | 6.54e-01 | 5.04e-01 | 2.57e+00 | 1.00e-02 | 1.29e-02 | 1.50e-01 |
| LUSC | cg19828220 | chr17:48605051 | CGI:chr17:48607882-48608087 | promoter | 4.89e-01 | 3.74e-01 | 2.25e+00 | 2.47e-02 | 2.82e-02 | 1.15e-01 |
| LUSC | cg10906729 | chr17:48605028 | CGI:chr17:48607882-48608087 | promoter | 5.14e-01 | 2.87e-01 | 2.02e+00 | 4.38e-02 | 4.48e-02 | 2.26e-01 |
| LUSC | cg18684142 | chr17:48605032 | CGI:chr17:48607882-48608087 | promoter | 6.40e-01 | 4.65e-01 | 2.11e+00 | 3.53e-02 | 3.76e-02 | 1.75e-01 |
| LUSC | cg02574073 | chr17:48605036 | CGI:chr17:48607882-48608087 | promoter | 6.41e-01 | 4.57e-01 | 2.13e+00 | 3.29e-02 | 3.55e-02 | 1.83e-01 |
| LUSC | cg04435975 | chr17:48605685 | CGI:chr17:48607882-48608087 | promoter | 6.85e-01 | 4.44e-01 | 3.15e+00 | 1.63e-03 | 3.62e-03 | 2.41e-01 |
| LUSC | cg20591728 | chr17:48606244 | CGI:chr17:48607882-48608087 | promoter | 9.52e-01 | 7.30e-01 | 4.29e+00 | 1.78e-05 | 5.26e-04 | 2.22e-01 |
| LUSC | cg18878432 | chr17:48606047 | CGI:chr17:48607882-48608087 | promoter | 8.75e-01 | 6.16e-01 | 4.18e+00 | 2.94e-05 | 5.26e-04 | 2.59e-01 |
| COAD | cg19828220 | chr17:48605051 | CGI:chr17:48607882-48608087 | promoter | 2.08e-01 | 3.16e-01 | -4.03e+00 | 5.67e-05 | 2.23e-04 | -1.08e-01 |
| COAD | cg15435170 | chr17:48603773 | CGI:chr17:48607882-48608087 | promoter,gene body | 2.30e-01 | 3.40e-01 | -4.03e+00 | 5.67e-05 | 2.23e-04 | -1.10e-01 |
| COAD | cg17179862 | chr17:48604000 | CGI:chr17:48607882-48608087 | promoter,gene body | 1.51e-01 | 2.56e-01 | -3.54e+00 | 4.05e-04 | 1.08e-03 | -1.06e-01 |
| COAD | cg03803541 | chr17:48604039 | CGI:chr17:48607882-48608087 | promoter,gene body | 1.67e-01 | 2.68e-01 | -3.46e+00 | 5.43e-04 | 1.37e-03 | -1.01e-01 |
| COAD | cg18684142 | chr17:48605032 | CGI:chr17:48607882-48608087 | promoter | 1.49e-01 | 3.13e-01 | -3.70e+00 | 2.15e-04 | 6.48e-04 | -1.64e-01 |
| COAD | cg02574073 | chr17:48605036 | CGI:chr17:48607882-48608087 | promoter | 1.50e-01 | 2.80e-01 | -3.94e+00 | 8.29e-05 | 3.02e-04 | -1.29e-01 |
| COAD | cg20591728 | chr17:48606244 | CGI:chr17:48607882-48608087 | promoter | 6.78e-01 | 8.97e-01 | -1.98e+00 | 4.79e-02 | 4.84e-02 | -2.19e-01 |
| COAD | cg01986016 | chr17:48603792 | CGI:chr17:48607882-48608087 | promoter,gene body | 2.21e-01 | 3.23e-01 | -3.99e+00 | 6.60e-05 | 2.52e-04 | -1.02e-01 |
| COAD | cg20471691 | chr17:48603954 | CGI:chr17:48607882-48608087 | promoter,gene body | 2.59e-01 | 3.89e-01 | -3.94e+00 | 8.09e-05 | 2.96e-04 | -1.30e-01 |
| COAD | cg16848873 | chr17:48604946 | CGI:chr17:48607882-48608087 | promoter | 1.69e-01 | 2.91e-01 | -3.91e+00 | 9.17e-05 | 3.28e-04 | -1.22e-01 |
| LIHC | cg19828220 | chr17:48605051 | CGI:chr17:48607882-48608087 | promoter | 2.32e-01 | 3.41e-01 | -4.24e+00 | 2.22e-05 | 5.49e-05 | -1.09e-01 |
| LIHC | cg18684142 | chr17:48605032 | CGI:chr17:48607882-48608087 | promoter | 2.45e-01 | 4.03e-01 | -3.11e+00 | 1.88e-03 | 2.77e-03 | -1.58e-01 |
| LIHC | cg02574073 | chr17:48605036 | CGI:chr17:48607882-48608087 | promoter | 2.74e-01 | 3.86e-01 | -2.16e+00 | 3.08e-02 | 3.27e-02 | -1.12e-01 |
| LIHC | cg20471691 | chr17:48603954 | CGI:chr17:48607882-48608087 | promoter,gene body | 3.05e-01 | 4.16e-01 | -4.03e+00 | 5.48e-05 | 1.21e-04 | -1.11e-01 |
| LIHC | cg16848873 | chr17:48604946 | CGI:chr17:48607882-48608087 | promoter | 2.29e-01 | 3.59e-01 | -5.20e+00 | 2.00e-07 | 9.43e-07 | -1.30e-01 |
| LIHC | cg05888755 | chr17:48604957 | CGI:chr17:48607882-48608087 | promoter | 2.30e-01 | 3.60e-01 | -4.60e+00 | 4.25e-06 | 1.30e-05 | -1.29e-01 |
| KIRP | cg04435975 | chr17:48605685 | CGI:chr17:48607882-48608087 | promoter | 5.06e-01 | 2.96e-01 | 2.38e+00 | 1.74e-02 | 2.05e-02 | 2.10e-01 |
| CHOL | cg03803541 | chr17:48604039 | CGI:chr17:48607882-48608087 | promoter,gene body | 4.21e-01 | 1.91e-01 | 1.99e+00 | 4.65e-02 | 4.65e-02 | 2.30e-01 |
| CHOL | cg04435975 | chr17:48605685 | CGI:chr17:48607882-48608087 | promoter | 4.89e-01 | 2.35e-01 | 2.29e+00 | 2.23e-02 | 3.24e-02 | 2.53e-01 |
| CHOL | cg20591728 | chr17:48606244 | CGI:chr17:48607882-48608087 | promoter | 9.28e-01 | 6.58e-01 | 3.46e+00 | 5.30e-04 | 8.63e-03 | 2.70e-01 |
| CHOL | cg18878432 | chr17:48606047 | CGI:chr17:48607882-48608087 | promoter | 7.58e-01 | 5.39e-01 | -2.43e+00 | 1.50e-02 | 2.65e-02 | 2.19e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg19828220 | chr17:48605051 | CGI:chr17:48607882-48608087 | promoter | 4.51e-01 | 2.80e-01 | 8.73e+00 | 2.52e-18 | 1.19e-17 | 1.71e-01 |
| BRCA | cg17179862 | chr17:48604000 | CGI:chr17:48607882-48608087 | promoter,gene body | 2.65e-01 | 1.29e-01 | 5.86e+00 | 4.75e-09 | 1.09e-08 | 1.36e-01 |
| BRCA | cg03803541 | chr17:48604039 | CGI:chr17:48607882-48608087 | promoter,gene body | 2.45e-01 | 1.11e-01 | 6.90e+00 | 5.34e-12 | 1.55e-11 | 1.33e-01 |
| BRCA | cg10906729 | chr17:48605028 | CGI:chr17:48607882-48608087 | promoter | 5.04e-01 | 1.70e-01 | 7.38e+00 | 1.54e-13 | 5.04e-13 | 3.34e-01 |
| BRCA | cg18684142 | chr17:48605032 | CGI:chr17:48607882-48608087 | promoter | 6.21e-01 | 2.69e-01 | 5.56e+00 | 2.71e-08 | 5.83e-08 | 3.52e-01 |
| BRCA | cg02574073 | chr17:48605036 | CGI:chr17:48607882-48608087 | promoter | 6.35e-01 | 3.04e-01 | 4.79e+00 | 1.63e-06 | 2.96e-06 | 3.31e-01 |
| BRCA | cg04435975 | chr17:48605685 | CGI:chr17:48607882-48608087 | promoter | 4.70e-01 | 2.98e-01 | 5.95e+00 | 2.63e-09 | 6.17e-09 | 1.72e-01 |
| BRCA | cg21387752 | chr17:48602926 | CGI:chr17:48597682-48598227 | promoter,gene body | 2.37e-01 | 1.15e-01 | 9.17e+00 | 4.58e-20 | 2.49e-19 | 1.21e-01 |
| BRCA | cg16848873 | chr17:48604946 | CGI:chr17:48607882-48608087 | promoter | 4.39e-01 | 2.80e-01 | 6.45e+00 | 1.13e-10 | 2.96e-10 | 1.59e-01 |
| BRCA | cg05888755 | chr17:48604957 | CGI:chr17:48607882-48608087 | promoter | 4.20e-01 | 2.35e-01 | 6.12e+00 | 9.09e-10 | 2.22e-09 | 1.85e-01 |
| LUAD | cg19828220 | chr17:48605051 | CGI:chr17:48607882-48608087 | promoter | 4.82e-01 | 3.62e-01 | 2.43e+00 | 1.52e-02 | 2.12e-02 | 1.20e-01 |
| LUAD | cg03803541 | chr17:48604039 | CGI:chr17:48607882-48608087 | promoter,gene body | 4.24e-01 | 3.13e-01 | 1.97e+00 | 4.83e-02 | 4.87e-02 | 1.11e-01 |
| LUAD | cg10906729 | chr17:48605028 | CGI:chr17:48607882-48608087 | promoter | 5.15e-01 | 3.20e-01 | 1.97e+00 | 4.83e-02 | 4.87e-02 | 1.95e-01 |
| LUAD | cg18684142 | chr17:48605032 | CGI:chr17:48607882-48608087 | promoter | 6.40e-01 | 4.42e-01 | 2.24e+00 | 2.48e-02 | 3.02e-02 | 1.98e-01 |
| LUAD | cg02574073 | chr17:48605036 | CGI:chr17:48607882-48608087 | promoter | 6.44e-01 | 4.63e-01 | 2.10e+00 | 3.56e-02 | 3.91e-02 | 1.81e-01 |
| LUAD | cg04435975 | chr17:48605685 | CGI:chr17:48607882-48608087 | promoter | 5.79e-01 | 4.22e-01 | 2.50e+00 | 1.24e-02 | 1.84e-02 | 1.57e-01 |
| LIHC | cg20591728 | chr17:48606244 | CGI:chr17:48607882-48608087 | promoter | 7.07e-01 | 5.49e-01 | 2.96e+00 | 3.07e-03 | 5.45e-03 | 1.58e-01 |
| LIHC | cg18878432 | chr17:48606047 | CGI:chr17:48607882-48608087 | promoter | 5.14e-01 | 3.78e-01 | 2.25e+00 | 2.47e-02 | 2.85e-02 | 1.36e-01 |
| KIRP | cg17179862 | chr17:48604000 | CGI:chr17:48607882-48608087 | promoter,gene body | 1.55e-01 | 5.36e-02 | 3.02e+00 | 2.50e-03 | 6.82e-03 | 1.02e-01 |
| KIRP | cg02574073 | chr17:48605036 | CGI:chr17:48607882-48608087 | promoter | 1.73e-01 | 6.86e-02 | 2.33e+00 | 2.00e-02 | 2.67e-02 | 1.04e-01 |
Top |
Exon skipping events with PSI in TCGA for HOXB3 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for HOXB3 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for HOXB3 |
| TFs related to HOXB3. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| SKCM | AIRE | HOXB3 | 2.79e+00 | 1.44e-03 | 4.36e+00 | 9.83e-01 | Female-biased |
| SKCM | BARX2 | HOXB3 | 2.82e+00 | 1.83e-04 | 4.97e+00 | 9.93e-01 | Female-biased |
| SKCM | FOXD2 | HOXB3 | 2.34e+00 | 1.29e-04 | 4.59e+00 | 9.88e-01 | Female-biased |
| SKCM | FOXR2 | HOXB3 | 1.68e+00 | 8.35e-06 | 4.76e+00 | 9.91e-01 | Female-biased |
| SKCM | GATA1 | HOXB3 | 4.80e+00 | 6.03e-03 | 5.95e+00 | 9.93e-01 | Female-biased |
| SKCM | HOMEZ | HOXB3 | 4.94e+00 | 4.38e-03 | 6.19e+00 | 9.95e-01 | Female-biased |
| SKCM | HOXC13 | HOXB3 | 6.42e+00 | 1.92e-02 | 7.19e+00 | 9.80e-01 | Female-biased |
| SKCM | LHX3 | HOXB3 | 2.41e+00 | 1.89e-04 | 4.55e+00 | 9.87e-01 | Female-biased |
| SKCM | MEIS1 | HOXB3 | 3.37e+00 | 1.96e-03 | 4.86e+00 | 9.90e-01 | Female-biased |
| SKCM | MEOX2 | HOXB3 | 2.67e+00 | 7.08e-04 | 4.45e+00 | 9.85e-01 | Female-biased |
| SKCM | MYNN | HOXB3 | 2.28e+00 | 1.07e-04 | 4.57e+00 | 9.88e-01 | Female-biased |
| SKCM | NKX6-1 | HOXB3 | 1.77e+00 | 2.90e-05 | 4.45e+00 | 9.86e-01 | Female-biased |
| SKCM | NKX6-3 | HOXB3 | 3.00e+00 | 1.80e-03 | 4.51e+00 | 9.85e-01 | Female-biased |
| SKCM | NR4A2 | HOXB3 | 3.10e+00 | 2.50e-03 | 4.51e+00 | 9.84e-01 | Female-biased |
| SKCM | PDX1 | HOXB3 | 3.15e+00 | 5.61e-04 | 5.01e+00 | 9.93e-01 | Female-biased |
| SKCM | SOX18 | HOXB3 | 2.73e+00 | 5.40e-04 | 4.59e+00 | 9.88e-01 | Female-biased |
| SKCM | SOX4 | HOXB3 | 2.52e+00 | 5.45e-04 | 4.36e+00 | 9.84e-01 | Female-biased |
| SKCM | SOX6 | HOXB3 | 2.80e+00 | 1.02e-03 | 4.47e+00 | 9.85e-01 | Female-biased |
| SKCM | SRF | HOXB3 | 3.16e+00 | 2.90e-03 | 4.53e+00 | 9.84e-01 | Female-biased |
| SKCM | ZFP82 | HOXB3 | 2.04e+00 | 9.21e-05 | 4.38e+00 | 9.84e-01 | Female-biased |
| SKCM | ZNF317 | HOXB3 | 2.62e+00 | 9.33e-04 | 4.32e+00 | 9.82e-01 | Female-biased |
| SKCM | ZNF410 | HOXB3 | 3.47e+00 | 5.46e-03 | 4.64e+00 | 9.83e-01 | Female-biased |
| SKCM | ZNF570 | HOXB3 | 1.35e+00 | 1.47e-05 | 4.24e+00 | 9.81e-01 | Female-biased |
| SKCM | ZNF595 | HOXB3 | 3.30e+00 | 5.13e-03 | 4.49e+00 | 9.81e-01 | Female-biased |
| HOXB3 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
 |
Top |
Sex-biased RBP-ES network for HOXB3 |
| RBPs related to ES in HOXB3. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| HOXB3 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000120093 | ARHGAP27P1-BPTFP1-KPNA2P3,hsa-mir-372,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | AC092171.5,hsa-mir-372,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | AC026362.1,hsa-mir-372,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | AC087741.1,hsa-mir-375,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | AL358072.1,hsa-mir-519b,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | AC026362.1,hsa-mir-519b,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | AC087741.1,hsa-mir-665,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | AL162431.1,hsa-mir-665,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | RPARP-AS1,hsa-mir-665,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | LINC01089,hsa-mir-665,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | AC026362.1,hsa-mir-665,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | ZFHX2-AS1,hsa-mir-665,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | ZKSCAN2-DT,hsa-mir-665,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | ARHGAP27P1-BPTFP1-KPNA2P3,hsa-mir-665,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | AC232271.1,hsa-mir-665,HOXB3 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000120093 | KCNQ1OT1,hsa-mir-375,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | GARS1-DT,hsa-mir-375,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | LINC01011,hsa-mir-454,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | KCNQ1OT1,hsa-mir-454,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | THBS3-AS1,hsa-mir-454,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | AC007066.2,hsa-mir-454,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | AC048344.4,hsa-mir-454,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | AC004812.2,hsa-mir-454,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | Z95331.1,hsa-mir-454,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | KCNQ1OT1,hsa-mir-485,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | Z95331.1,hsa-mir-485,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | Z92544.1,hsa-mir-485,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | AC068790.9,hsa-mir-485,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | GARS1-DT,hsa-mir-485,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | AC019205.1,hsa-mir-485,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | AC007066.2,hsa-mir-485,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | AC232271.1,hsa-mir-485,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | KCNQ1OT1,hsa-mir-655,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | Z95331.1,hsa-mir-655,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | AC048344.4,hsa-mir-655,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000120093 | AL121839.2,hsa-mir-655,HOXB3 | Female-specific ceRNA | TCGA-LIHC |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs138269231 | chr17:49419949:C:T | - | 0.350658382605657 | 0.0120577062259928 | PAAD | Female-baised eQTL |
| rs140513518 | chr17:39337327:G:C | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs143688322 | chr17:39342552:A:G | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs16965088 | chr17:39343361:A:C | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs56102014 | chr17:39352643:T:G | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs72825148 | chr17:39374199:T:A | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs72825164 | chr17:39385712:G:A | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs151100079 | chr17:39417917:G:A | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs72825178 | chr17:39418311:A:C | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs56143149 | chr17:39419421:T:C | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs4412996 | chr17:39437184:G:A | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs72825188 | chr17:39440282:T:A | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs72825189 | chr17:39441285:G:A | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs72825194 | chr17:39459811:G:C | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs4611492 | chr17:39460084:T:C | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs142468090 | chr17:39480999:A:C | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs145915418 | chr17:39482043:G:A | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs147692437 | chr17:39489184:A:C | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs144132310 | chr17:39491361:C:T | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs72827114 | chr17:39510091:C:T | - | 0.121326602869997 | 0.0148875039390639 | SARC | Female-baised eQTL |
| rs144242511 | chr17:39520516:G:A | - | 0.117434042303322 | 0.0168222007391353 | SARC | Female-baised eQTL |
| rs72827126 | chr17:39543946:G:C | - | 0.117434042303322 | 0.0168222007391353 | SARC | Female-baised eQTL |
| rs149369324 | chr17:39544677:C:T | - | 0.117434042303322 | 0.0168222007391353 | SARC | Female-baised eQTL |
| rs72827138 | chr17:39578728:G:A | - | 0.117434042303322 | 0.0168222007391353 | SARC | Female-baised eQTL |
| rs72827139 | chr17:39579216:C:A | - | 0.117434042303322 | 0.0168222007391353 | SARC | Female-baised eQTL |
| rs72827140 | chr17:39579868:C:T | - | 0.117434042303322 | 0.0168222007391353 | SARC | Female-baised eQTL |
| rs140840990 | chr17:39581058:C:T | - | 0.117434042303322 | 0.0168222007391353 | SARC | Female-baised eQTL |
| rs151136817 | chr17:39581236:G:A | - | 0.117434042303322 | 0.0168222007391353 | SARC | Female-baised eQTL |
| rs117075427 | chr17:39582433:A:G | - | 0.117434042303322 | 0.0168222007391353 | SARC | Female-baised eQTL |
| rs142296901 | chr17:39583244:G:A | - | 0.117434042303322 | 0.0168222007391353 | SARC | Female-baised eQTL |
| rs35091825 | chr17:48032062:T:C | - | 0.193751972236762 | 0.0193909039978479 | STAD | Female-baised eQTL |
| rs7209072 | chr17:48033103:A:G | - | 0.173356108880162 | 0.0257015852811339 | STAD | Female-baised eQTL |
| rs16969990 | chr17:48153529:C:T | - | 0.194727343712937 | 0.0285055555929361 | STAD | Female-baised eQTL |
| rs11079810 | chr17:48150484:C:T | - | 0.158572126075203 | 0.0345038838713614 | STAD | Female-baised eQTL |
| rs28660978 | chr17:54471181:G:C | - | 0.0659579338888181 | 0.0179915439889775 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs9901481 | chr17:39593558:T:C | - | 0.115039233656897 | 0.00304309297686571 | KIRC | Male-baised eQTL |
| rs56845786 | chr17:39595752:T:G | - | 0.150028312748143 | 0.0175230088602704 | KIRC | Male-baised eQTL |
| rs8069438 | chr17:39325139:C:T | - | 0.0957958167563797 | 0.0194718697804456 | KIRC | Male-baised eQTL |
| rs34458385 | chr17:39582245:A:G | - | 0.101211227018577 | 0.0211192219937609 | KIRC | Male-baised eQTL |
| rs8081144 | chr17:39567038:G:A | - | 0.0992151874133932 | 0.0254572119420538 | KIRC | Male-baised eQTL |
| rs35442489 | chr17:39569882:G:A | - | 0.0992151874133932 | 0.0254572119420538 | KIRC | Male-baised eQTL |
| rs35270682 | chr17:39571415:T:A | - | 0.0992151874133932 | 0.0254572119420538 | KIRC | Male-baised eQTL |
| rs36172452 | chr17:39580908:A:G | - | 0.0992151874133932 | 0.0254572119420538 | KIRC | Male-baised eQTL |
| rs59373279 | chr17:39590036:T:C | - | 0.100154569971998 | 0.0299940134706125 | KIRC | Male-baised eQTL |
| rs9899652 | chr17:39615699:G:A | - | 0.101673824777285 | 0.0387355622796028 | KIRC | Male-baised eQTL |
| rs72827166 | chr17:39618736:C:T | - | 0.101673824777285 | 0.0387355622796028 | KIRC | Male-baised eQTL |
| rs9892853 | chr17:39625235:C:T | - | 0.10162540864633 | 0.0391460609772233 | KIRC | Male-baised eQTL |
| rs1431316 | chr17:56073949:C:T | - | 0.0825831501305761 | 0.0412547665353873 | KIRC | Male-baised eQTL |
| rs12603341 | chr17:46119464:G:A | - | 0.126935619722571 | 9.54099462155465e-05 | BLCA | Male-baised eQTL |
| rs4792834 | chr17:46142126:T:C | - | 0.126867292376741 | 9.72468634319078e-05 | BLCA | Male-baised eQTL |
| rs4792833 | chr17:46142008:C:A | - | 0.125292745975824 | 0.000139002649471403 | BLCA | Male-baised eQTL |
| rs117079030 | chr17:46054051:G:A | - | 0.114409395832493 | 0.00332622741782942 | BLCA | Male-baised eQTL |
| rs74536520 | chr17:46055082:C:T | - | 0.114409395832493 | 0.00332622741782942 | BLCA | Male-baised eQTL |
| rs12449717 | chr17:46057588:G:C | - | 0.114409395832493 | 0.00332622741782942 | BLCA | Male-baised eQTL |
| rs117795466 | chr17:46107156:T:A | - | 0.114063281803047 | 0.00350092487641671 | BLCA | Male-baised eQTL |
| rs8078249 | chr17:56860542:A:G | - | 0.0493483779178873 | 0.00383851650759425 | BLCA | Male-baised eQTL |
| rs2301732 | chr17:46066848:T:C | - | 0.113265217261121 | 0.00395070504274752 | BLCA | Male-baised eQTL |
| rs7209198 | chr17:56832043:G:A | - | 0.0470186416092721 | 0.0117577472415674 | BLCA | Male-baised eQTL |
| rs6503772 | chr17:56839328:A:C | - | 0.0451792096262754 | 0.0135392266110323 | BLCA | Male-baised eQTL |
| rs9889321 | chr17:56815352:T:C | - | 0.0447535105568071 | 0.016619805528769 | BLCA | Male-baised eQTL |
| rs17833388 | chr17:56812518:C:T | - | 0.0433916380982064 | 0.0246160703476157 | BLCA | Male-baised eQTL |
| rs769071 | chr17:40874140:T:C | - | 0.0448552275536953 | 0.0265623974344025 | BLCA | Male-baised eQTL |
| rs73990421 | chr17:55509384:G:T | - | 0.084827917828968 | 0.0308045703163095 | BLCA | Male-baised eQTL |
| rs11658180 | chr17:56810991:G:A | - | 0.0413305794751321 | 0.0389457209742259 | BLCA | Male-baised eQTL |
| rs2116228 | chr17:56022338:C:G | - | -0.0416087508642807 | 0.0460116778095043 | BLCA | Male-baised eQTL |
| rs7225287 | chr17:55915659:C:A | - | 0.127059640668448 | 0.000764809870882687 | COAD | Male-baised eQTL |
| rs8076068 | chr17:55787659:A:G | - | 0.127281566222411 | 0.00108680880471201 | COAD | Male-baised eQTL |
| rs57786749 | chr17:55788685:T:C | - | 0.127281566222411 | 0.00108680880471201 | COAD | Male-baised eQTL |
| rs34608325 | chr17:55789708:G:A | - | 0.127281566222411 | 0.00108680880471201 | COAD | Male-baised eQTL |
| rs200838195 | chr17:55790728:C:T | - | 0.127281566222411 | 0.00108680880471201 | COAD | Male-baised eQTL |
| rs11868867 | chr17:55793290:G:A | - | 0.127281566222411 | 0.00108680880471201 | COAD | Male-baised eQTL |
| rs8077069 | chr17:55797091:C:G | - | 0.127281566222411 | 0.00108680880471201 | COAD | Male-baised eQTL |
| rs55841188 | chr17:55804065:C:G | - | 0.127281566222411 | 0.00108680880471201 | COAD | Male-baised eQTL |
| rs8070672 | chr17:55808155:A:G | - | 0.127281566222411 | 0.00108680880471201 | COAD | Male-baised eQTL |
| rs7223534 | chr17:55809270:T:C | - | 0.127281566222411 | 0.00108680880471201 | COAD | Male-baised eQTL |
| rs73314343 | chr17:55780783:A:G | - | 0.127178646770779 | 0.00109923650535463 | COAD | Male-baised eQTL |
| rs7215926 | chr17:55783518:C:A | - | 0.127178646770779 | 0.00109923650535463 | COAD | Male-baised eQTL |
| rs9901908 | chr17:40499463:C:T | - | -0.111559524955994 | 0.0015178228496052 | COAD | Male-baised eQTL |
| rs896135 | chr17:40495580:T:C | - | -0.107943785661604 | 0.00397764086163195 | COAD | Male-baised eQTL |
| rs4890087 | chr17:40497014:G:A | - | -0.109622992577957 | 0.00456335767776921 | COAD | Male-baised eQTL |
| rs7342935 | chr17:52349932:C:T | - | 0.0591559665129257 | 0.0058852436837763 | COAD | Male-baised eQTL |
| rs8082703 | chr17:52350911:C:T | - | 0.0591559665129257 | 0.0058852436837763 | COAD | Male-baised eQTL |
| rs4343332 | chr17:52353825:G:A | - | 0.0591559665129257 | 0.0058852436837763 | COAD | Male-baised eQTL |
| rs8079371 | chr17:52354268:G:C | - | 0.0591559665129257 | 0.0058852436837763 | COAD | Male-baised eQTL |
| rs7208179 | chr17:52354807:G:C | - | 0.0578029917762315 | 0.00750635178334541 | COAD | Male-baised eQTL |
| rs7214428 | chr17:52354970:T:C | - | 0.0578029917762315 | 0.00750635178334541 | COAD | Male-baised eQTL |
| rs4534899 | chr17:52355897:C:T | - | 0.0578029917762315 | 0.00750635178334541 | COAD | Male-baised eQTL |
| rs9674705 | chr17:52356172:C:T | - | 0.0578029917762315 | 0.00750635178334541 | COAD | Male-baised eQTL |
| rs1854267 | chr17:52356771:C:T | - | 0.0578029917762315 | 0.00750635178334541 | COAD | Male-baised eQTL |
| rs1843705 | chr17:52343184:G:A | - | 0.0580734892233758 | 0.00827601995598753 | COAD | Male-baised eQTL |
| rs11869229 | chr17:55789660:T:C | - | 0.115734182721551 | 0.0086251661300406 | COAD | Male-baised eQTL |
| rs12051898 | chr17:55802661:C:T | - | 0.115734182721551 | 0.0086251661300406 | COAD | Male-baised eQTL |
| rs201526597 | chr17:55791654:C:A | - | 0.115529414457117 | 0.00895618764352337 | COAD | Male-baised eQTL |
| rs2290433 | chr17:55822779:C:T | - | 0.115004694155221 | 0.00944006173597512 | COAD | Male-baised eQTL |
| rs6503543 | chr17:40496592:A:G | - | -0.0987504415486234 | 0.00988419863697125 | COAD | Male-baised eQTL |
| rs7226352 | chr17:52357768:A:T | - | 0.0560794560904582 | 0.0104617430200832 | COAD | Male-baised eQTL |
| rs2631534 | chr17:52335025:G:A | - | 0.0568488144421416 | 0.011688961587763 | COAD | Male-baised eQTL |
| rs921394 | chr17:40499967:C:T | - | -0.0978352565854361 | 0.0125298410117922 | COAD | Male-baised eQTL |
| rs9898336 | chr17:55909429:A:G | - | 0.103342162343109 | 0.0127215400270336 | COAD | Male-baised eQTL |
| rs61396478 | chr17:55912643:G:A | - | 0.103342162343109 | 0.0127215400270336 | COAD | Male-baised eQTL |
| rs170492 | chr17:38881518:G:C | - | 0.062532707846954 | 0.0157411560702692 | COAD | Male-baised eQTL |
| rs8070795 | chr17:52354576:T:C | - | 0.0548071470936623 | 0.015898975099866 | COAD | Male-baised eQTL |
| rs9898067 | chr17:52334479:A:G | - | 0.0548309558642746 | 0.0166092611421597 | COAD | Male-baised eQTL |
| rs9889963 | chr17:51391264:T:C | - | 0.122031897150525 | 0.0186637708310377 | COAD | Male-baised eQTL |
| rs1431315 | chr17:56073934:T:G | - | 0.071825257520969 | 0.0190869256935559 | COAD | Male-baised eQTL |
| rs1431316 | chr17:56073949:C:T | - | 0.071825257520969 | 0.0190869256935559 | COAD | Male-baised eQTL |
| rs9897851 | chr17:55913174:T:C | - | 0.0935053324609297 | 0.0246160882082579 | COAD | Male-baised eQTL |
| rs2585839 | chr17:58062850:C:T | - | -0.0542805673185674 | 0.0351771687294988 | COAD | Male-baised eQTL |
| rs2052189 | chr17:56361403:A:T | - | -0.0513057994037403 | 0.0442499219516996 | COAD | Male-baised eQTL |
| rs9897985 | chr17:55987238:G:C | - | 0.096214313662741 | 0.0480833806536651 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg00690402 | |
| Position to Gene: gene | |
| Male Effect: -0.381695306842512 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg17144149 | |
| Position to Gene: gene | |
| Male Effect: -0.121503151883398 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg05387167 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: - | |
| Female Effect: -0.340526735962903 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg20184247 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.340526735962903 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg07676709 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.340526735962903 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg05555337 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.470038806316212 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg23014425 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.468563929794261 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg04800503 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.468563929794261 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg06186155 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.468563929794261 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg00646731 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.468563929794261 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg05487507 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.468563929794261 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg00682096 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.468563929794261 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg26916621 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.240094684225306 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg22660299 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.253225726864137 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg01629240 | |
| Position to Gene: gene | |
| Male Effect: -0.148312422518597 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg00842549 | |
| Position to Gene: gene | |
| Male Effect: 0.0578495060570465 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg15649236 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.436198178160157 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg00711072 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.339763404564496 | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg01593673 | |
| Position to Gene: gene | |
| Male Effect: -0.178124195930475 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg22583148 | |
| Position to Gene: gene | |
| Male Effect: -0.165468817398772 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg24210813 | |
| Position to Gene: gene | |
| Male Effect: -0.173735765642413 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg02642822 | |
| Position to Gene: gene | |
| Male Effect: -0.139497405547168 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg07676709 | |
| Position to Gene: gene | |
| Male Effect: -0.186871575642434 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg23217463 | |
| Position to Gene: gene | |
| Male Effect: -0.172011960288998 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg08832695 | |
| Position to Gene: gene | |
| Male Effect: -0.182035658367581 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg27656658 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: -0.212708504237578 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg00682096 | |
| Position to Gene: gene | |
| Male Effect: -0.223922039518848 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg21864868 | |
| Position to Gene: gene | |
| Male Effect: -0.246943815924613 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg05487507 | |
| Position to Gene: gene | |
| Male Effect: -0.193490583088196 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg20184247 | |
| Position to Gene: gene | |
| Male Effect: -0.198580981244879 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg00690402 | |
| Position to Gene: gene | |
| Male Effect: -0.178377432584219 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg17616537 | |
| Position to Gene: gene | |
| Male Effect: -0.222268726213555 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg21872782 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: -0.195550946704298 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg16787431 | |
| Position to Gene: gene | |
| Male Effect: -0.208056034011937 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg06186155 | |
| Position to Gene: gene | |
| Male Effect: -0.209279773116104 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg19986012 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: -0.205037732329621 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg22660299 | |
| Position to Gene: gene | |
| Male Effect: -0.192678722207473 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg02458062 | |
| Position to Gene: gene,exon,CDS,UTR | |
| Male Effect: -0.241881588268486 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg05387167 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: -0.236765946458197 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg24761525 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: -0.132245850053437 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg23507953 | |
| Position to Gene: gene | |
| Male Effect: -0.162964705013572 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg13609544 | |
| Position to Gene: gene | |
| Male Effect: -0.15513977390614 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg04800503 | |
| Position to Gene: gene | |
| Male Effect: -0.153093903202551 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg23014425 | |
| Position to Gene: gene | |
| Male Effect: -0.156345437942171 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg03019986 | |
| Position to Gene: gene | |
| Male Effect: -0.170378691802404 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg15065049 | |
| Position to Gene: gene | |
| Male Effect: -0.240275371433247 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg18127922 | |
| Position to Gene: gene | |
| Male Effect: -0.238660468211278 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg20152430 | |
| Position to Gene: gene | |
| Male Effect: -0.0535070080545971 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg00411072 | |
| Position to Gene: gene | |
| Male Effect: -0.201321541314289 | |
| Female Effect: - | |
 | Gene ID: ENSG00000120093 |
| CpG Site: cg02873421 | |
| Position to Gene: gene | |
| Male Effect: -0.188523298296146 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg00690402 | chr17:48592204 | gene | -0.381695306842512 | 1.30397878407596e-06 | -0.4043215261362768 | 2.6388437794613775e-09 | KIRP |
| cg17144149 | chr17:48579210 | gene | -0.121503151883398 | 2.28311599513503e-05 | -0.38529580921446926 | 1.5219243435341087e-07 | KIRC |
| cg01629240 | chr17:48564649 | gene | -0.148312422518597 | 5.60573654213154e-07 | -0.3960806595397173 | 1.1126194620241731e-09 | STAD |
| cg00842549 | chr17:48574558 | gene | 0.0578495060570465 | 2.29824608172831e-06 | 0.3442131414757921 | 1.6205815674236589e-09 | SKCM |
| cg01593673 | chr17:48570652 | gene | -0.178124195930475 | 4.40332622627947e-45 | -0.7362225099649311 | 2.5726939520045486e-53 | BLCA |
| cg22583148 | chr17:48596679 | gene | -0.165468817398772 | 2.50949326758765e-37 | -0.6991574107298939 | 4.6090141656104525e-46 | BLCA |
| cg24210813 | chr17:48592282 | gene | -0.173735765642413 | 3.75382751199593e-35 | -0.6852311701341358 | 1.2825857585528104e-43 | BLCA |
| cg02642822 | chr17:48589564 | gene | -0.139497405547168 | 2.12931126749131e-33 | -0.6711707234909655 | 2.7605053272364493e-41 | BLCA |
| cg07676709 | chr17:48596080 | gene | -0.186871575642434 | 4.79730182424859e-33 | -0.6650451662147383 | 2.6163174450393306e-40 | BLCA |
| cg23217463 | chr17:48599611 | gene | -0.172011960288998 | 9.14682637485311e-32 | -0.6570723710095019 | 4.516495703585229e-39 | BLCA |
| cg08832695 | chr17:48599013 | gene | -0.182035658367581 | 9.68017828265543e-32 | -0.6438869355019143 | 4.1709037470519165e-37 | BLCA |
| cg27656658 | chr17:48550862 | gene,exon,CDS | -0.212708504237578 | 1.20229156197764e-26 | -0.6136670577989073 | 6.013344293993742e-33 | BLCA |
| cg00682096 | chr17:48595562 | gene | -0.223922039518848 | 4.22419790626751e-24 | -0.5878800901749351 | 9.747038234144876e-30 | BLCA |
| cg21864868 | chr17:48595640 | gene | -0.246943815924613 | 1.45203358507379e-23 | -0.5769432185582265 | 1.8426726261132653e-28 | BLCA |
| cg05487507 | chr17:48594499 | gene | -0.193490583088196 | 3.04911055774855e-23 | -0.5717580653407062 | 7.146768225751209e-28 | BLCA |
| cg20184247 | chr17:48594690 | gene | -0.198580981244879 | 4.51707117922726e-22 | -0.574100590223673 | 3.885615287575915e-28 | BLCA |
| cg00690402 | chr17:48592204 | gene | -0.178377432584219 | 5.15004963995231e-22 | -0.5779643107428901 | 1.4069803240943246e-28 | BLCA |
| cg17616537 | chr17:48551301 | gene | -0.222268726213555 | 2.50328868011022e-21 | -0.5578149163730665 | 2.4346959099966705e-26 | BLCA |
| cg21872782 | chr17:48553268 | gene,exon,UTR | -0.195550946704298 | 2.58194259114258e-21 | -0.5698882074654864 | 1.1583651146372561e-27 | BLCA |
| cg16787431 | chr17:48551988 | gene | -0.208056034011937 | 3.55835049453704e-18 | -0.5231176928651764 | 7.979539379814717e-23 | BLCA |
| cg06186155 | chr17:48571220 | gene | -0.209279773116104 | 4.06523109155616e-18 | -0.5307748998113476 | 1.4478250602253827e-23 | BLCA |
| cg19986012 | chr17:48550486 | gene,exon,CDS | -0.205037732329621 | 3.2484448182198e-17 | -0.5231369744972311 | 7.94574746822871e-23 | BLCA |
| cg22660299 | chr17:48591353 | gene | -0.192678722207473 | 9.58480621616019e-17 | -0.5142361707760086 | 5.477337469652561e-22 | BLCA |
| cg02458062 | chr17:48552316 | gene,exon,CDS,UTR | -0.241881588268486 | 1.8679799188501e-16 | -0.48457544047127266 | 2.3000327144004536e-19 | BLCA |
| cg05387167 | chr17:48552442 | gene,exon,CDS | -0.236765946458197 | 1.54286378753353e-15 | -0.48021305505485035 | 5.326749204257458e-19 | BLCA |
| cg24761525 | chr17:48574383 | gene,exon,UTR | -0.132245850053437 | 1.44564431421186e-13 | -0.49354754765267544 | 3.9356148792691805e-20 | BLCA |
| cg23507953 | chr17:48560765 | gene | -0.162964705013572 | 2.82557556752249e-12 | -0.46969111892300786 | 3.846205614632318e-18 | BLCA |
| cg13609544 | chr17:48587285 | gene | -0.15513977390614 | 4.89216314746669e-12 | -0.4639826973442217 | 1.0929466154918027e-17 | BLCA |
| cg04800503 | chr17:48571171 | gene | -0.153093903202551 | 8.55212867467137e-10 | -0.42366083092800105 | 1.026565624891688e-14 | BLCA |
| cg23014425 | chr17:48571163 | gene | -0.156345437942171 | 2.37538798603856e-09 | -0.39537677310703345 | 7.450539048884168e-13 | BLCA |
| cg03019986 | chr17:48551488 | gene | -0.170378691802404 | 1.1727209718048e-08 | -0.3808994091293685 | 5.733272179213169e-12 | BLCA |
| cg15065049 | chr17:48551656 | gene | -0.240275371433247 | 2.03298391884251e-07 | -0.3489782240325608 | 3.6627338770642304e-10 | BLCA |
| cg18127922 | chr17:48594893 | gene | -0.238660468211278 | 2.66734535358853e-07 | -0.3411821358468208 | 9.440879050513107e-10 | BLCA |
| cg20152430 | chr17:48564142 | gene | -0.0535070080545971 | 3.37766856801347e-07 | -0.36073763268726916 | 9.632874352809109e-11 | BLCA |
| cg00411072 | chr17:48583578 | gene | -0.201321541314289 | 5.96378696441336e-07 | -0.32443626414891813 | 6.6149004271702615e-09 | BLCA |
| cg02873421 | chr17:48551944 | gene | -0.188523298296146 | 4.8233471447833e-06 | -0.312542580739473 | 2.4580165706466518e-08 | BLCA |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg05387167 | chr17:48552442 | gene,exon,CDS | -0.340526735962903 | 2.15143416358263e-16 | -0.5318391213808868 | 5.0629164254715334e-20 | LUAD |
| cg20184247 | chr17:48594690 | gene | -0.340526735962903 | 2.15143416358263e-16 | -0.5318391213808868 | 5.0629164254715334e-20 | LUAD |
| cg07676709 | chr17:48596080 | gene | -0.340526735962903 | 2.15143416358263e-16 | -0.5318391213808868 | 5.0629164254715334e-20 | LUAD |
| cg05555337 | chr17:48591751 | gene | -0.470038806316212 | 1.54836476859284e-15 | -0.5652323639131436 | 1.3666322506514556e-22 | LUAD |
| cg23014425 | chr17:48571163 | gene | -0.468563929794261 | 2.01069862407931e-15 | -0.5180235368379262 | 6.539930239647038e-19 | LUAD |
| cg04800503 | chr17:48571171 | gene | -0.468563929794261 | 2.01069862407931e-15 | -0.5180235368379262 | 6.539930239647038e-19 | LUAD |
| cg06186155 | chr17:48571220 | gene | -0.468563929794261 | 2.01069862407931e-15 | -0.5180235368379262 | 6.539930239647038e-19 | LUAD |
| cg00646731 | chr17:48591371 | gene | -0.468563929794261 | 2.01069862407931e-15 | -0.5180235368379262 | 6.539930239647038e-19 | LUAD |
| cg05487507 | chr17:48594499 | gene | -0.468563929794261 | 2.01069862407931e-15 | -0.5180235368379262 | 6.539930239647038e-19 | LUAD |
| cg00682096 | chr17:48595562 | gene | -0.468563929794261 | 2.01069862407931e-15 | -0.5180235368379262 | 6.539930239647038e-19 | LUAD |
| cg26916621 | chr17:48579984 | gene | -0.240094684225306 | 2.33557747078145e-11 | -0.46065650683617676 | 8.44845016042192e-15 | LUAD |
| cg22660299 | chr17:48591353 | gene | -0.253225726864137 | 4.85435946885668e-08 | -0.39825262621885804 | 4.014782734279806e-11 | LUAD |
| cg15649236 | chr17:48580142 | gene | -0.436198178160157 | 1.04257760630875e-11 | -0.538105711394826 | 7.96169357330543e-15 | SKCM |
| cg00711072 | chr17:48592127 | gene | -0.339763404564496 | 3.11270824412155e-06 | -0.43425862822286776 | 1.2529338842787835e-09 | SKCM |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of HOXB3 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000120093 | HOXB3 | C0019284 | Diaphragmatic Hernia | 1 | CTD_human |
